Oppenheimer downgraded Carlyle Group from Outperform to Perform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/19/2025 | Outperform → Perform | Oppenheimer | |
| 1/3/2025 | $60.00 | Peer Perform → Outperform | Wolfe Research |
| 9/12/2024 | $42.00 | Equal Weight | Wells Fargo |
| 8/27/2024 | $55.00 | Buy | Redburn Atlantic |
| 8/6/2024 | $46.00 → $44.00 | Overweight → Neutral | JP Morgan |
| 1/19/2024 | $40.00 → $41.00 | Buy → Neutral | Citigroup |
| 1/4/2024 | $42.00 | Market Perform | TD Cowen |
| 11/29/2023 | $32.00 | Outperform → In-line | Evercore ISI |
SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt
MCLEAN, Va., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, today announced the appointment of Calder Lynch and Jami Snyder to its healthcare advisory board. With decades of experience leading state and federal government healthcare programs, the subject matter experts will advise the company and its clients on healthcare policies and trends as well as strategies to improve health outcomes at a lower cost. "We are excited to welcome Calder Lynch and Jami Snyder to Acentra Health's Healthcare Advisory Boar
MCLEAN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced it has appointed Ezmeralda Sager as Executive Vice President and Chief Transformation Officer (CTO), effective January 6, 2025. In this role, Sager will spearhead enterprise-wide change initiatives to help Acentra Health build upon its strong track record of innovation and execution for its clients. She will provide strategic guidance on process improvements to optimize the development and delivery of the company's products, solutions
MCLEAN, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, today celebrates the state of Utah and the Utah Department of Health and Human Services (DHHS) for achieving Centers for Medicare & Medicaid Services (CMS) certification of the Provider Reimbursement Information System for Medicaid (PRISM). This achievement affirms the successful modernization of Utah Medicaid's core claims payment and eligibility system, designed, built, and implemented in partnership with Acentra Health. Utah's accomplishment rec
Suntera Global ("Suntera"), the Jersey headquartered, independent provider of bespoke fund, corporate and private wealth services, today announced it has entered into an agreement with Valeas Capital Partners ("Valeas"), a growth-oriented equity investment firm, to acquire a majority stake in Suntera. Under terms of the agreement, Valeas is committing significant new equity capital to support the expansion of Suntera's capabilities and footprint globally and power its continued digital transformation. Founded in 1980, Suntera provides a full suite of professional services to corporates, fund managers, and private clients, including their family offices. Through a comprehensive range of adm
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its first quarter ended March 31, 2025. Justin Plouffe, CGBD's Chief Executive Officer, said, "Following successful completion of the merger with CSL III at the end of March, CGBD remains focused on driving stable income, consistent credit performance, and disciplined execution of our strategy. Complementing our conservative investing approach, we continue to optimize the capital structure of CGBD, increasing total commitments on our credit facility and exchanging the pre
DEFA14A - Carlyle Group Inc. (0001527166) (Filer)
DEF 14A - Carlyle Group Inc. (0001527166) (Filer)
SCHEDULE 13G/A - Carlyle Group Inc. (0001527166) (Subject)
Oppenheimer downgraded Carlyle Group from Outperform to Perform
Wolfe Research upgraded Carlyle Group from Peer Perform to Outperform and set a new price target of $60.00
Wells Fargo initiated coverage of Carlyle Group with a rating of Equal Weight and set a new price target of $42.00
4 - Carlyle Group Inc. (0001527166) (Issuer)
4 - Carlyle Group Inc. (0001527166) (Issuer)
4 - Carlyle Group Inc. (0001527166) (Issuer)
SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)
SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)
SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its first quarter ended March 31, 2025. Justin Plouffe, CGBD's Chief Executive Officer, said, "Following successful completion of the merger with CSL III at the end of March, CGBD remains focused on driving stable income, consistent credit performance, and disciplined execution of our strategy. Complementing our conservative investing approach, we continue to optimize the capital structure of CGBD, increasing total commitments on our credit facility and exchanging the pre
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Tuesday, May 20, 2025, for its second quarter of 2025. CCIF will host a conference call at 10:00 a.m. EST on Wednesday, May 21, 2025, to discuss the results. The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and will also be available on the website soon after the call's completion. About Carlyle Credit Income Fund Carlyle Credit Income Fund (NYSE:CCIF) is an externally managed closed-end f
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. EST on Wednesday, May 7, 2025 to announce its financial results for the first quarter ended March 31, 2025. The Company will report its quarterly financial results on Tuesday, May 6, 2025. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc. Carlyle Secured Lending, Inc. is a publicly traded (NASDAQ:CGBD) business development company (